REGULATION OF NEOPLASTIC T-LYMPHOCYTE AND HEMATOPOIETIC CELL PROLIFERATION

肿瘤 T 淋巴细胞和造血细胞增殖的调节

基本信息

  • 批准号:
    4692223
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Binding of the regulatory peptide, interleukin-2 (IL-2), to its specific receptor is a prerequisite for activated T lymphocytes to grow. Deprivation of IL-2 from T-cells results in all the cells coming to rest in GO. Recombinant, purified IL-2 was used to identify biochemical parameters associated with stimulation of these resting T-cells into cell cycle progression. Calcium levels, measured spectrophotometrically using Quin-2 dye, were markedly increased within one minute. No increase was observed with a non-homologous ligand. Also, it was shown that IL-2 stimulates rapid turnover in the phosphoinositol pathway followed by hydrolysis of phosphoinositides. It has been recently demonstrated that IL-2 binding produces a rapid and transient redistribution of protein kinase C (PK-C) from cytosol to cell membrane. This PK-C activity was correlated with the ability of T-cells to express T-cell receptors on their cell surface. Using radiolabeled IL-2 binding and cytofluorometric assays for anti-Tac, a monoclonal antibody to the IL-2 receptor, IL-2 was shown to stimulate increased IL-2 receptor expression on T-cells within 24 hrs. An increased level of IL-2 receptor became detectible by 4 hrs. Analysis of IL-2 receptor numbers after IL-2 stimulation showed major differences between IL-2 (6-9,000 per cell) and anti-Tac (35-45,000 per cell) binding. Resting, previously activated cells stimulated with phorbol esters have nearly equal numbers of binding sites with both ligands. Scatchard analysis of data reveals that the number of binding sites with high affinity (greater than 10-10M) correlated with IL-2 binding numbers and not with anti-Tac binding. Thus, IL-2 stimulation of T-cell growth results in an increased number of Tac antigen binding sites with lower affinity on the cell surface. Herpes-viruses, such as Herpesvirus saimiri (HVS), and RNA tumor viruses, such as Human T-cell leukemia virus (HTLV), can transform T-cells. Studies on metabolic events and IL-2 receptor regulation have shown major differences of growth control between normal and such transformed T-cells.
调节肽白细胞介素-2(IL-2)与其特异性结合 受体是活化的T淋巴细胞生长的先决条件。 从T细胞中去除IL-2导致所有细胞在体内休息。 走了 重组、纯化的IL-2用于鉴定生化参数 与刺激这些静止的T细胞进入细胞周期有关 进展 钙水平,使用Quin-2通过电化学计量法测量 染料,在一分钟内显著增加。 未观察到增加 与非同源配体结合 此外,研究表明,IL-2刺激 磷酸肌醇途径中的快速周转,随后水解 磷酸肌醇。 最近已经证明,IL-2结合 产生蛋白激酶C(PK-C)的快速和短暂的重新分布 从细胞质到细胞膜。 这种PK-C活性与 T细胞在其细胞表面表达T细胞受体的能力。 使用放射性标记的IL-2结合和细胞荧光测定抗Tac, IL-2受体的单克隆抗体,IL-2显示刺激 在24小时内增加T细胞上的IL-2受体表达。 增加 IL-2受体水平在4小时时变得可检测。 IL-2分析 IL-2刺激后的受体数量显示, IL-2(6- 9,000/细胞)和抗Tac(35- 45,000/细胞)结合。 静止的,先前用佛波醇酯刺激的活化细胞, 与两种配体的结合位点的数量几乎相等。 Scatchard 数据分析表明,高结合位点的数量 亲和力(大于10- 10 M)与IL-2结合数相关, 与抗Tac抗体结合 因此,IL-2刺激T细胞生长导致 增加的Tac抗原结合位点的数量, 细胞表面 疱疹病毒,如松鼠猴疱疹病毒(HVS)和RNA 肿瘤病毒,如人T细胞白血病病毒(HTLV),可以转化 T细胞 对代谢事件和IL-2受体调节的研究已经 显示出正常和这种生长控制之间的主要差异, 转化的T细胞

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

F W RUSCETTI其他文献

F W RUSCETTI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('F W RUSCETTI', 18)}}的其他基金

INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3838183
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3853293
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3896343
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3874512
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3752469
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3838187
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF NORMAL AND NEOPLASTIC HEMATOPOIETIC CELL GROWTH--ROLE OF BRMS
正常和肿瘤造血细胞生长的调节——BRMS 的作用
  • 批准号:
    3916663
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
NEOPLASTIC HEMATOPOIETIC CELL GROWTH--INTERACTIONS WITH RETROVIRUSES
肿瘤造血细胞生长——与逆转录病毒的相互作用
  • 批准号:
    3963338
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3853290
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
INTERACTIONS OF HUMAN RETROVIRUSES WITH HEMATOPOIETIC AND ADHERENT CELLS
人类逆转录病毒与造血细胞和贴壁细胞的相互作用
  • 批准号:
    3752465
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了